comparemela.com
  1. Home
  2. Live Updates
  3. Mike Kratky - Breaking News

Latest Breaking News On - Mike kratky - Page 3 : comparemela.com

Kymera Therapeutics, Inc (NASDAQ:KYMR) Q4 2022 Earnings Call Transcript

Operator: Hello, and welcome to the Kymera Therapeutics Fourth Quarter 2022 Earnings Conference Call. Please note, this event is being recorded.

United statesKalpit patelMike kratkyAndrew fleszarPaul jengRaymond jamesRebecca mosherDerek archilaBruce jacobsVikram purohitZhi shuMarc frahmJohn reedZhiqiang shuJared gollobNello mainolfi

Pliant shares jump on new data for lung disease drug

BioPharma

Mike kratkyBoehringer ingelheim ofevRoche esbrietBrian abrahamsAlex thompsonPliant therapeuticsBoehringer ingelheimClinical trials

Madrigal Pharmaceuticals Gets Price Target Bumps By Analysts Following Successful NASH Study

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) announced positive topline results from the pivotal Phase 3 MAESTRO-NASH biopsy trial of resmetirom. M.

Jay olsonEd arceMike kratkyJonathan wollebenGoldman sachsMadrigal pharmaceuticalsMadrigal pharmaceuticals incHc wainwright coAndrea tan

MannKind Corporation (MNKD) Q3 2022 Earnings Call Transcript

MNKD earnings call for the period ending September 30, 2022.

Mike kratkyGregory renzaSteven binderMichael castagnaBrandon folkes cantor fitzgeraldRobert hazlettSteven lichtmanRobert hazlettThomas smithBrandon folkesExchange commissionMannkind corporationCantor fitzgeraldCf foundationMotley fool stock advisorStock advisor

CymaBay Therapeutics Inc (CBAY) Q1 2022 Earnings Call Transcript

CBAY earnings call for the period ending March 31, 2022.

United statesSan diegoMike kratkyEd arceRaymond jamesDan menoldMayank mamtaniSteven seedhouse raymond jamesZhib rileySteven seedhouseJay olson oppenheimerPaul quinlanKristen kluskaJay olsonEmma nesson piper sandlerBettina hansen

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.